Zobrazeno 1 - 10
of 80
pro vyhledávání: '"J. Thielke"'
Autor:
Bruce Kaplan, Enrico Benedetti, Patricia West-Thielke, J. Thielke, Sally Campbell-Lee, Heather J Ipema
Publikováno v:
Transplantation Proceedings. 53:1548-1553
Background Recipients of ABO-incompatible (ABOI) and positive crossmatch (PXM) kidney transplants are at high risk for antibody-mediated acute rejection. Despite aggressive immunosuppression in high-risk patients, the incidence of acute rejection rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc16ce456a603faba8b33fecae94ae9
https://doi.org/10.1016/j.transproceed.2021.01.010
https://doi.org/10.1016/j.transproceed.2021.01.010
Autor:
D. J. Thielke
Publikováno v:
New England Review. 40:37-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e44842768fcdd5a76a9afcb03c0112f4
https://doi.org/10.1353/ner.2019.0084
https://doi.org/10.1353/ner.2019.0084
Autor:
D. J. Thielke
Publikováno v:
Colorado Review. 44:57-67
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ae95a7e81b4792760fd4be6be8bbd68
https://doi.org/10.1353/col.2017.0089
https://doi.org/10.1353/col.2017.0089
Autor:
Eric Wenzler, Shane Brandt, Shitalben R. Patel, J. Thielke, Patricia West-Thielke, Enrico Benedetti, Shree Patel, Natalia M. Jasiak‐Panek, Yi‐jen Huang, Kristin Progar
Publikováno v:
Clinical Transplantation. 33
Purpose Tacrolimus extended-release (TAC-ER; Astagraf XL® ) is utilized in many immunosuppressive regimens post-renal transplantation. Current dosing recommendation for the TAC-ER in renal transplant is 0.15-0.2 mg/kg/day administered once daily. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a7804b675b488d1cf3f19d961b1ce7
https://doi.org/10.1111/ctr.13640
https://doi.org/10.1111/ctr.13640
Autor:
Nancy L. Shapiro, Robert J. DiDomenico, Kirsten H. Ohler, Shellee A. Grim, Andrew J. Donnelly, J. Thielke, Jeffrey J. Mucksavage, Juliana Chan, Eljim P. Tesoro, Edith A. Nutescu, S. Bathija, Janet P. Engle, John Garofalo
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 34:1239-1249
Study Objectives To characterize the balance of clinical and academic responsibilities of clinical track pharmacy faculty in the United States and evaluate organizational structures that promote satisfactory balance between these responsibilities. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073990545739184f168e8ae16c5e6a8b
https://doi.org/10.1002/phar.1521
https://doi.org/10.1002/phar.1521
Autor:
Kirstie K. Danielson, Bryan N. Becker, Raquel Garcia-Roca, Hoonbae Jeon, Katie Kinzer, Pier Cristoforo Giulianotti, Anand Patel, Ignatius Tang, Ivo Tzvetanov, S. Akkina, Lorena Bejarano-Pineda, Subhashini Ayloo, Francesco Bianco, J. Thielke, Jose Oberholzer, Enrico Benedetti, Mario Spaggiari
Publikováno v:
American Journal of Transplantation. 13:721-728
Epidemiological data indicate that 20-50% of patients on dialysis for end-stage renal disease (ESRD) are obese (body mass index [BMI] ≥30 kg/m2) (1). Obese patients with chronic renal failure have longer wait times until kidney transplantation (2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0abd3809ed44f0c2000f58109906853
https://doi.org/10.1111/ajt.12078
https://doi.org/10.1111/ajt.12078
Autor:
J. Joseph, Enrico Benedetti, Jose Oberholzer, Hoonbae Jeon, Mario Spaggiari, J. Thielke, Ivo Tzvetanov
Publikováno v:
Transplantation Proceedings. 44:2971-2975
Antibody-mediated rejection (AMR) typically occurs early after transplantation in approximately 5%-7% of recipients. The literature reports suggest that 12%-37% of kidney transplant recipients with acute AMR do not respond to treatment and eventually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d1207fd133d1769268ab8ae4f197b6
https://doi.org/10.1016/j.transproceed.2012.02.037
https://doi.org/10.1016/j.transproceed.2012.02.037
Autor:
Amanda Stephenson, Patricia West-Thielke, J. Thielke, Jose Oberholzer, Kirstie K. Danielson, Mario Spaggiari, Bruce Kaplan, Enrico Benedetti, Hoonbae Jeon, Ivo Tzvetanov, Suman Setty
Publikováno v:
Transplantation. 94:255-262
BACKGROUND: In the treatment of refractory antibody-mediated rejection (AMR), splenectomy has been associated with surprisingly rapid recovery of renal function. The mechanism is still unclear. METHODS: We review 11 recipients, who underwent rescue s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4223c935951b15239a1db5f6945df7f
https://doi.org/10.1097/tp.0b013e3182562881
https://doi.org/10.1097/tp.0b013e3182562881
Autor:
Howard Sankary, Patricia West-Thielke, Jose Oberholzer, Enrico Benedetti, Bruce Kaplan, J. Thielke, Sally Campbell-Lee, Umberto Bareato, Vladimir Vidanovic, Ivo Tzvetanov, Thuy Ommert, Heather Herren
Publikováno v:
Transplantation. 87:268-273
Background To increase living donation for kidney transplantation, we investigated desensitization of recipients with positive crossmatch against a potential living donor. Methods Between June 2001 and March 2007, 57 consecutive sensitized candidates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e52e01d1822cdda12fe017d6876bd1
https://doi.org/10.1097/tp.0b013e3181919a16
https://doi.org/10.1097/tp.0b013e3181919a16
Autor:
Howard Sankary, Enrico Benedetti, Jose Oberholzer, Thuy Pham, J. Thielke, Nina M. Clark, Shellee A. Grim
Publikováno v:
Clinical Transplantation. 21:628-632
Immunosuppressive protocols for ABO-incompatible (ABOI) and positive cross-match (PCM) solid organ transplant (SOT) recipients have included the use of rituximab (RTX). Infectious complications (IC) have been reported after the use of RTX for other i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218b18f43e90950c04bd809961a7c2ea
https://doi.org/10.1111/j.1399-0012.2007.00700.x
https://doi.org/10.1111/j.1399-0012.2007.00700.x